DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @Tickeron | 9 |
| @ProTradersNews | 4 |
| @TickerReport | 2 |
| @confcalltran | 2 |
| @ConsumerFeed | 2 |
Recent Tweets for MYGN
 |
@Tickeron $MYGN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 14, 2019. View odds for t… https://t.co/6eOsP1Y2iz October 21st 2019, 2:10pm |
 |
@myriadgenetics Dr. Mark H. Pollack named Chief Medical Officer for Myriad Neuroscience. Learn more: https://t.co/WBQCKO3VcD $MYGN… https://t.co/cFdNOQVOVz October 21st 2019, 11:10am |
 |
@newswithvalue $AMRX $MYGN: Is Amneal Pharmaceuticals, Inc. (AMRX) Going To Burn These …: https://t.co/e87IlIbJKt October 21st 2019, 10:10am |
 |
@ProTradersNews $EURN $MYGN: Is InterDigital, Inc. (IDCC) A Good Stock To Buy?: https://t.co/8TclthX0vF October 21st 2019, 10:10am |
|
@ProTradersNews $IVR $MYGN: Is Invesco Mortgage Capital Inc (IVR) A Good Stock To Buy?: https://t.co/v0QlTJqT4R October 21st 2019, 10:10am |
|
@ProTradersNews $MYGN $CNDT: Hedge Funds Aren’t Crazy About Myriad Genetics, Inc. (MYGN …: https://t.co/gp2u6gRmWJ October 21st 2019, 9:10am |
 |
@StockTexts $MYGN Dr. Mark H. Pollack named Chief Medical Officer for Myriad Neuroscience Nasdaq:MYGN https://t.co/jMzFSVxPSB October 21st 2019, 7:10am |
 |
@newsfilterio Dr. Mark H. Pollack named Chief Medical Officer for Myriad Neuroscience $MYGN https://t.co/lydaP7zjNh October 21st 2019, 7:10am |
|
@Tickeron $MYGN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 14, 2019. View odds for t… https://t.co/BG9DSb5TEd October 20th 2019, 2:10pm |
|
@Tickeron $MYGN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 14, 2019. View odds for t… https://t.co/gV2katoSHo October 19th 2019, 5:10pm |
|
@Tickeron $MYGN in Downtrend: 50-day Moving Average moved below 200-day Moving Average on October 14, 2019. View odds for thi… https://t.co/m6Ck5GROPu October 18th 2019, 8:10pm |
 |
@macondailynews $203.04 Million in Sales Expected for Myriad Genetics, Inc. $MYGN This Quarter https://t.co/PE9eWfjMcx October 17th 2019, 11:10pm |
 |
@dakotafinancial Zacks: Analysts Expect Myriad Genetics, Inc. $MYGN Will Announce Earnings of $0.33 Per Share https://t.co/GZFeMU9qqp October 17th 2019, 11:10pm |
 |
@TheMarketsDaily $203.04 Million in Sales Expected for Myriad Genetics, Inc. $MYGN This Quarter https://t.co/HymqfNXIkB October 17th 2019, 11:10pm |
 |
@newswelldone $NVTA $MYGN: InVitae Shares Bounce Back Following Analyst Rebuttal To Short …: https://t.co/oodAcAWmLZ October 17th 2019, 11:10am |
|
@Tickeron $MYGN in Uptrend: Stochastic indicator stays in overbought zone for 1 day. View odds for this and other indicators:… https://t.co/GLoOhIFZSf October 16th 2019, 4:10pm |
 |
@ThomasUBarton1 2. I forgot to add, a substantial loss from their SHORT in $mygn. October 16th 2019, 4:10pm |
 |
@1MinuteStock Btw, Estimated #Earnings Per Share for $MYGN is $0.25 it's 0.84% of the current price https://t.co/yCdUvlSyzl October 16th 2019, 12:10pm |
 |
@SwingTradeBot Recent $MYGN technical alerts: Doji - Bearish? plus 4 more alerts... https://t.co/1ayvR7H0Cj October 16th 2019, 12:10pm |
 |
@confcalltran Myriad: Fee Computed On Table Below Per Exchange Act Rules https://t.co/abYe3wEyUN $MYGN October 16th 2019, 12:10pm |
|
@confcalltran Myriad Genetics releases salary data. CEO sees compensation rise 26%25 https://t.co/3QEm3quz59 $MYGN October 16th 2019, 11:10am |
 |
@ExecPayOrg Myriad Genetics CEO Mark Capone's 2019 pay jumps 26% to $8.9M https://t.co/vxeFGIrHIy $MYGN #execpay October 16th 2019, 11:10am |
 |
@fintel_io $MYGN / Myriad Genetics files form DEF 14A https://t.co/k8YsD8EolX October 16th 2019, 11:10am |
 |
@ConsumerFeed Myriad Genetics, Inc. $MYGN Short Interest Update https://t.co/7rxZOGCwSO October 16th 2019, 4:10am |
 |
@TickerReport $203.04 Million in Sales Expected for Myriad Genetics, Inc. $MYGN This Quarter https://t.co/7bzvjjmiFy October 15th 2019, 10:10am |
 |
@bbnsnews Myriad Genetics, Inc. $MYGN Expected to Post Earnings of $0.26 Per Share https://t.co/QT4WdCAOUD October 15th 2019, 10:10am |
 |
@WatchlistN Myriad Genetics, Inc. $MYGN Expected to Post Quarterly Sales of $203.04 Million https://t.co/L57ff859VG October 15th 2019, 10:10am |
 |
@IRAMarketReport Zacks: Analysts Anticipate Myriad Genetics, Inc. $MYGN Will Post Earnings of $0.26 Per Share https://t.co/FFPXGeNR34 #markets October 15th 2019, 10:10am |
 |
@chaffeybreeze Zacks: Analysts Anticipate Myriad Genetics, Inc. $MYGN Will Post Earnings of $0.26 Per Share https://t.co/8IKedyv0L2 #stocks October 15th 2019, 10:10am |
 |
@HeadlinesFin $0.26 EPS Expected for Myriad Genetics, Inc. $MYGN https://t.co/n7ODlTKVl7 October 15th 2019, 12:10am |
 |
@AmericanBanking Short Interest in Myriad Genetics, Inc. $MYGN Grows By 14.2% https://t.co/GxiMjvyiVV #stocks October 14th 2019, 1:10pm |
|
@TickerReport Short Interest in Myriad Genetics, Inc. $MYGN Grows By 14.2% https://t.co/amsvnxhSCi October 14th 2019, 1:10pm |
 |
@dailypoliticaln Short Interest in Myriad Genetics, Inc. $MYGN Grows By 14.2% https://t.co/75pO22Cdct October 14th 2019, 1:10pm |
|
@newswelldone $MYGN: Glancy Prongay & Murray Reminds Investors of Looming Deadline …: https://t.co/V43pkhtMD7 October 14th 2019, 11:10am |
|
@Tickeron $MYGN in Downtrend: its price may drop because broke its higher Bollinger Band on September 24, 2019. View odds for… https://t.co/2cP0DpuxAK October 14th 2019, 12:10am |
|
@ConsumerFeed $0.33 EPS Expected for Myriad Genetics, Inc. $MYGN This Quarter https://t.co/sKF20iAjGA October 13th 2019, 8:10am |
 |
@gcassidy718 $MYGN stock is up 2.32 % with an ok PE 472.92 and beta 1.10 https://t.co/3H5kqTuzLf October 12th 2019, 11:10pm |
 |
@MarketChmln $MYGN upcoming event October 15: 2019 American Society of Human Genetics Annual Meeting. Options expiring on Octobe… https://t.co/Tj4F91KMg5 October 12th 2019, 10:10am |
 |
@BlueBioNow $MYGN wow what a great surprise 3.28 % https://t.co/tW3cQXvdPM October 12th 2019, 12:10am |
 |
@NewsToDesk $MYGN: Deadline Reminder: The Law Offices of Howard G. Smith Reminds …: https://t.co/HuW27ErhUT October 11th 2019, 11:10am |
 |
@ThisLincolnian Brokerages Expect Myriad Genetics, Inc. $MYGN Will Announce Earnings of $0.33 Per Share https://t.co/dyoX1lTNGz October 10th 2019, 9:10pm |
|
@Tickeron $MYGN in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on September 18, 2019. View odds for t… https://t.co/eP7NcO5csI October 10th 2019, 5:10pm |
|
@ProTradersNews $MYGN: Myriad Genetics Investors: Filing Deadline in MYGN Class Action …: https://t.co/T4ij8iUcJZ October 10th 2019, 3:10pm |
 |
@StockTipRobot New Wikileaks docs say now is the time to consider selling Myriad Genetics $MYGN #ProTip October 10th 2019, 12:10pm |
|
@Tickeron $MYGN in Uptrend: 50-day Moving Average broke above 200-day Moving Average on September 18, 2019. View odds for thi… https://t.co/PP8j5aQ9Um October 9th 2019, 4:10pm |
|
@Tickeron $MYGN in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on September 24, 2019. View o… https://t.co/BbtY7zjN5o October 8th 2019, 3:10pm |
 |
@FlashAlert_me $MYGN: Press Release published article on October 08, 07:05:00: Myriad Genetics to Present Five Studies at the 2019… https://t.co/TYuo6AxphR October 8th 2019, 7:10am |
 |
@thegreenisback Here's Why Myriad Genetics Jumped 21.7% in September @themotleyfool #stocks $MYGN https://t.co/hCPm3goAQQ October 7th 2019, 3:10pm |
|
@Tickeron $MYGN in Downtrend: Stochastic indicator recovers from overbought zone. View odds for this and other indicators:… https://t.co/uTvnqzoicB October 7th 2019, 2:10pm |
|
@newswelldone $MYGN: Here’s Why Myriad Genetics Jumped 21.7% in September: https://t.co/xAhrN0zPfB October 7th 2019, 2:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.